ArticleCancer imaging : the official publication of the International Cancer Imaging Society2025
Computed tomography-based unsupervised clustering identifies clusters associated with progression free survival in clear cell renal cell carcinoma.
Article in Cancer imaging : the official publication of the International Cancer Imaging Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThis study aimed to develop and validate a radiologic clustering model using CT imaging features to stratify clear cell renal cell carcinoma (ccRCC) patients by prognosis and identify key imaging predictors of 5-year progression free survival (PFS).
methodsThis retrospective study included 164 ccRCC patients with multiphase kidney CT and next-generation sequencing (NGS) between September 2003 and October 2024. Qualitative imaging features were extracted, and unsupervised consensus clustering was performed to classify tumors based on radiologic characteristics. A nomogram-based C1 score was derived from features predictive of the high-risk cluster. Model performance was evaluated using C-index and 5-year area under the receiver operating curve (AUC). Genetic alterations and copy number variations (CNVs) were also analyzed for associations with imaging features and survival.
resultsClustering revealed two distinct radiologic subtypes. Cluster C1 characterized by aggressive behavior such as tumor heterogeneity (p = 0.011), exophytic growth pattern (p = 0.002), non-smooth margin (p = 0.019), and renal sinus extension (p = 0.016), and was independently associated with poorer 5-year PFS (p = 0.018). The C1 score demonstrated an AUC of 0.992 for predicting cluster C1 in the test-set. Using a cutoff of 0.75, the model achieved 96.3% sensitivity and 96.4% specificity. For predicting 5-year PFS, the C1 score showed moderate performance (AUC 0.65; C-index 0.65), which improved when combined with nodal/distant metastasis and BAP1 mutation status (AUC 0.71; C-index 0.67).
conclusionsRadiologic clustering using CT features enables non-invasive prognostic stratification of ccRCC. The C1 score derived from this approach may serve as a practical tool to guide surveillance and treatment decisions.
trial registrationRetrospectively registered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.